2-(4,4-bis(Ethoxymethyl)cyclohex-1-en-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 97%, 100mg

Columnas de cromatografía con frita, núcleo de vidrio esmerilado y conexión de extracción GL 18, 35 ml, 15 mm, 200 mm, 1 Pieza(s)

(2-Fluoro-5-(morpholine-4-carbonyl)phenyl)boronic acid, 95.0%, 5g

1-Bromo-3-fluoro-5-nitrobenzene, 95.0%, 10g

2,4,6-Trifluoropyrimidine, 98.0%, 1g

(2-Amino-6-nitrophenyl)methanol, 95+%, 10g

TERT-BUTYL 3-BROMOPHENYL(METHYL)CARBAMATE, 95.0%, 5g

Tris(2-carboxyethyl) Isocyanurate>98.0%(T)500g

3,4,5-Trihydroxybenzaldehyde>98.0%(GC)(T)5g

1-(3,5-di-tert-butylphenyl)methanamine hydrochloride, 500mg

Revaprazan, 98%, 5mg

1-(6-(tert-Butyl)-1,1-dimethyl-2,3-dihydro-1H-inden-4-yl)ethanone, 95.0%, 500g

Quinuclidin-3-yl acetate, 95.0%, 100mg